Your bladder stores and eliminates urine. Bladder tumors can develop on the bladder wall or the urethra. Treatment for bladder tumors vary and depend on the grade (low or high) and how deep the tumor has invaded the bladder wall.
Tumors are classified based on their growth patterns. Papillary tumors are wart-like lesions attached to a stalk. Non-papillary tumors are solid lesions with a broad base. Non-papillary tumors are less common (10%) but tend to be more invasive.
Bladder cancer rarely occurs before age 40. Rates are higher for people who live in the northern half of the United States.
Sometimes there are no symptoms, but if you have bladder cancer you may notice one or more of these. It’s important to understand that the presence of these symptoms doesn’t necessarily mean you have cancer.
Researchers have found that key contributors of bladder cancer include smoking, some environmental toxins, age, and gender. Men are three times more likely than women to develop the disease, and 90% of those diagnosed are older than 55.
Research also has shown that exposure to certain chemicals, typically at industrial job sites, can contribute to the formation of tumors. A long-term bladder infection might also put you at risk.
What to know before your visit to Michigan Institute of Urology in Southeast Michigan:
Other tests that may be performed during or after your visit:
Fortunately, the rate of bladder cancer cases and deaths have declined an estimated 2% a year since 2015. Survival rates should continue to climb thanks to research studies that test new treatments, including drug therapies.
One significant advancement in treatment involves a group of drugs that guide your immune system to kill the cancer cells. These drugs, called immune checkpoint inhibitors, essentially teach your body to fight the disease itself.
Among minimally invasive treatments for patients in the earliest stages of the disease: